OpenAI 称 GPT-Rosalind 为神经退行性疾病药物发现提出新线索

OpenAI· @OpenAI · X·2026-10-21 21:32· 1 小时前AI 评分55

AI 导读

OpenAI 介绍 GPT-Rosalind 在药物发现中的新进展：针对与 Perry 综合征相关的 DCTN1 基因，模型在小鼠脑数据基础上提出胆固醇可能未能运输到神经元所需位置的机制假设，为神经退行性疾病治疗提供可验证方向。

正文 · 原文

GPT-Rosalind surfaced a new lead for drug discovery: could restoring cholesterol transport protect neurons from degeneration?

DCTN1 is a gene linked to Perry syndrome, a rare neurodegenerative disorder. In mouse-brain data, disrupting it increased expression of genes involved in making cholesterol. GPT-Rosalind suggested a possible explanation: cholesterol may not be reaching where neurons need it.

That gives scientists a specific mechanism to test and, if confirmed, a direction for developing new treatments for neurodegenerative disorders.

With @perturbai_tx and @scrippsresearch, a team of thousands of GPT-Rosalind agents worked in parallel, connecting gene-expression results from millions of mouse brain cells with scientific literature in just 32 minutes. We’re now expanding this collaboration to identify new drug targets.

https://openai.com/index/scaling-ai-research-for-complex-biological-data/

来源：OpenAI · x.com